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Purpose: Some lactobacilli, which possess superoxide dismutase-like activity and catalase 
activity naturally, have strong antioxidative properties. The aim of this study was to identify such 
strains and check which of them play a crucial role in alleviating intestinal inflammation.
Methods: We selected two Lactobacillus strains for use in animal studies: L. plantarum 30B 
(which has the highest catalase activity) and L. acidophilus 900 (which has the highest dismutase-
like activity). Forty mice (C57B1/6J) were divided into four experimental groups with ten mice 
in each group. Group I (control group) was not supplemented with Lactobacillus, group II (cata-
lase group) was orally supplemented with L. plantarum 30B, group III (dismutase-like group) 
was supplemented with L. acidophilus 900, and group IV (mixed group) was supplemented 
with both Lactobacillus strains. For 23 days, the temperature and body mass of each mouse 
were recorded and fecal samples for microbiological examination were collected. On day 23, 
the animals were sacrificed, and their intestines were removed for microbiological and histo-
pathological studies.
Results: Compared to the control group, the highest drop in the body temperature was observed 
in groups II (P,0.05) and IV (P,0.05). Similarly, groups II (P,0.05) and IV (P,0.05) had 
the highest drop in body mass. Moreover, histopathological evaluation of colon fragments 
showed intracryptic abscesses in these groups. Group III mice showed most limited degree of 
inflammation.
Conclusion: Lactobacillus strains with dismutase-like activity are more effective in alleviating 
intestinal inflammation than strains producing catalase, suggesting that superoxide anion radical 
decomposition is crucial in this process.
Keywords: probiotic strains, inflammatory bowel diseases, antioxidative enzymes, mouse 
model
Introduction
Inflammatory bowel diseases (IBD) are a group of chronic conditions of the gastro-
intestinal (GI) tract that comprise two principal types: Crohn’s disease and ulcerative 
colitis. The pathogenesis of IBD remains unclear. Researchers have identified that many 
genetic, immunological, and environmental factors, such as intestinal microbiota, diet, 
and chemical agents present in food and in the environment, likely play a role in IBD 
development.1,2 One of the various possible mechanisms involved in the initiation and 
perpetuation of IBD is free radical reactions, such as the imbalance between the levels of 
pro-oxidants and antioxidants.3 In the intestinal inflammatory processes, immune cells 
correspondence: Magdalena strus
Department of Microbiology, Jagiellonian 
University Medical college, 18 czysta 
street, 31 121 cracow, Poland
Tel +48 12 633 2567
Fax +48 12 423 3924
email mbstrus@cyf-kr.edu.pl 
Journal name: Drug Design, Development and Therapy
Article Designation: Original Research
Year: 2018
Volume: 12
Running head verso: Tomusiak-Plebanek et al
Running head recto: Lactobacilli with antioxidative activities in alleviating gut inflammation
DOI: 164559
 
D
ru
g 
D
es
ig
n,
 D
ev
el
op
m
en
t a
nd
 T
he
ra
py
 d
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//w
w
w
.d
ov
ep
re
ss
.c
om
/ b
y 
95
.1
74
.4
5.
14
5 
on
 2
8-
M
ar
-2
02
0
F
or
 p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Drug Design, Development and Therapy 2018:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3222
Tomusiak-Plebanek et al
contact antigens present in inflamed tissue and produce high 
levels of reactive oxygen species (ROS) such as hydroxyl 
radical (OH), superoxide anion (O
2
−), and hydrogen peroxide 
(H
2
O
2
).4 Exposure of the intestinal epithelial cells to ROS for 
a short period of time does not affect their function because 
they possess numerous protective mechanisms, including 
enzymes that inactivate ROS, such as catalase, peroxidase, or 
superoxide dismutase (SOD), and DNA repair mechanisms. 
However, in the case of chronic intestinal inflammation, the 
antioxidative protective mechanisms weaken, which leads 
to persistence of high ROS concentrations. This process 
damages the intestinal barrier, progresses the inflammation 
process, and injures the intestinal epithelium.5 Thus, increas-
ing the activity of antioxidative enzymes in inflamed mucosa 
of patients with IBD may be one way of suppressing the 
ongoing inflammation.
Antioxidative enzymes such as SOD or catalase are pro-
duced by the host cells and also by some commensal bacteria, 
which continuously colonize the GI tract.6 The Lactobacillus 
represent the genus of commensal bacteria permanently 
colonizing gut mucosa that may help preserve the biological 
balance between the amount of ROS and the activity of the 
antioxidative enzymes synthesized by the bacteria. In fact, 
some species belonging to this genus, such as L. delbrueckii, 
L. gasseri, and L. acidophilus can transform toxic O
2
− to less 
active H
2
O
2
:
 2O
2
− + 2H+ → H
2
O
2
 + O
2 
These Lactobacillus strains release H
2
O
2
 into the 
extracellular space, which can be detected by appropriate 
qualitative and quantitative assays. Selected Lactobacillus 
strains do not produce typical superoxide dismutase, but 
they use another mechanism: the dismutation reaction that 
is catalyzed by transition metal ions such as Mn2+.7,8
In addition, other species of Lactobacillus, such as 
L. plantarum, produce manganese pseudocatalase that con-
trols the transformation of H
2
O
2
 to water and oxygen.9
 2H
2
O
2
 → 2H
2
O + O
2 
The biological activity of this enzyme is similar to heme 
catalase, which is also present in other bacteria and eukary-
otic organisms.
Because lactobacilli have distinct antioxidative properties 
and are regarded as safe for humans and used as probiot-
ics, researchers are looking to lactobacilli to actively break 
down superoxide radicals and H
2
O
2
, thus restoring the 
oxidative–antioxidative balance in the intestinal mucosa. 
Thus far, studies using genetically modified lactobacilli 
expressing SOD show that administration of these strains 
positively influences the course of inflammation in animal 
models.10–12 Because the use of genetically modified bacteria 
in humans is not allowed, another approach was made by 
us to identify naturally occurring Lactobacillus strains with 
strong antioxidative properties. If these strains display anti-
inflammatory activity in sufficient amounts, they could then 
be used as active ingredients in future probiotic supplements. 
Such a postulate was raised by Mishra et al in their review 
paper.13 Therefore, the aim of this study was to evaluate 
antioxidative properties of lactobacilli that occur naturally 
in the alimentary tract, select strains showing the highest 
dismutase-like and/or catalase activity, and assess their influ-
ence on the course of the intestinal inflammation in a mouse 
model of IBD (C57B1/6J).
Materials and methods
Bacterial strains
Twenty-five lactobacilli strains were selected for the study 
that had been collected during the following research 
projects: QLGI-1999-00050 from FP7 project of UE; 
3PO5E 09125, and PO5A 09429 from the Polish National 
Research Center.
Detailed characteristics of strains are shown in 
Table 1. Each strain was then evaluated for its antioxidative 
properties.
analysis of antioxidative properties
Dismutase-like activity
To evaluate the ability of the bacteria to degrade superoxide 
anion radical to H
2
O
2
, we used two methods: 1) semiquan-
titative Peroxide Test Strip method (Merck, Darmstadt, 
Germany) and 2) quantitative DetectX SOD Colorimetric 
Activity Kit method (Arbor Assays, Ann Arbor, MI, USA).
1. The Peroxide Test Strip indicates the presence of H
2
O
2
 
by a color change on an indicator strip. The results are 
compared to a provided color scale. For this assay, 
Lactobacillus strains were cultured in MRS broth (Oxoid, 
Hampshire, UK) for 24 hours in aerobic conditions at 
37°C, and then the Peroxide Test Strip was performed as 
described by Strus et al.14 We measured H
2
O
2
 production 
in three time intervals: 0, 2, and 24 hours after the start.
2. The DetectX SOD Colorimetric Activity Kit quantitatively 
measures SOD activity in sonically disrupted bacterial 
cells. For the DetectX SOD test, Lactobacillus strains were 
suspended in 1 mL MRS broth to a final concentration of 
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1 × 108 colony-forming units (CFU)/mL. The culture was 
then incubated in aerobic conditions at 37°C for 2 hours. 
After incubation, the culture was centrifuged (8,000 rpm, 
5 minutes, 4°C), the supernatant was removed, and the 
remaining cell pellet was washed with 4°C phosphate 
buffered saline (PBS; Gibco, Waltham, MA, USA). This 
procedure was repeated twice. The samples were then 
sonicated on ice (5 minutes, amplitude 50%) and centri-
fuged (8,000 rpm, 5 minutes, 4°C). Then, the supernatant 
was collected, and SOD activity was measured accord-
ing to the manufacturer’s instructions. Absorbance was 
read at 450 nm using a spectrophotometer (Awareness 
Technology Inc., Palm City, FL, USA). SOD concentra-
tion was calculated according to a standard curve.
catalase activity
To examine catalase activity, we used the following 
methods: 1) semiquantitative Peroxide Test Strip method 
and 2) OxiSelect Hydrogen Peroxide Assay Kit method (Cell 
Biolabs, San Diego, CA, USA).
1. The semiquantitative Peroxide Test Strip was used 
after lactobacilli were cultured in 1 mL MRS broth for 
24 hours in aerobic conditions at 37°C. After centrifuga-
tion (3,000 rpm, 15 minutes at 4°C), the supernatant was 
removed, and the cell sediment was resuspended in 1 mL 
fresh MRS broth with chemically pure H
2
O
2
 (POCH, 
Gliwice, Poland) at a final concentration of 60 mg/L. The 
cultures were incubated at 37°C in aerobic conditions, and 
H
2
O
2
 concentration was measured at 0, 2, and 24 hours 
after the start.
2. For the OxiSelect Hydrogen Peroxide Assay Kit method, 
lactobacilli cultures were suspended in 1 mL MRS broth 
and incubated for 24 hours at 37°C in aerobic conditions. 
The cultures were centrifuged (3,000 rpm, 15 minutes), 
and the remaining cell sediment was resuspended in 1 mL 
PBS. Then H
2
O
2
 (30 mg/L final concentration) was added 
to all samples. We tested the catalase activity according 
to the manufacturer’s instructions. The absorbance was 
measured at 0, 2, and 24 hours using a spectrophotom-
eter (Awareness Technology Inc.) at 570 nm. The final 
concentrations of H
2
O
2
 were calculated based on a refer-
ence curve.
animal studies
animals
All experimental procedures were approved by the 
Local Ethics Committee for Experiments on Animals of 
Jagiellonian University in Krakow and were done according 
to the Directive 2010/63/EU of the European Parliament and 
of the European Council, September 22, 2010, on the protec-
tion of animals used for scientific purposes.
The experiments were performed on homozygotic 
C57Bl/6J mice with a mutation in the gene coding interleukin-10 
(IL-10−/−). Among the various rodent models for IBD, IL-10 
deficient mice are widely used for studies investigating the 
pathogenesis of spontaneous, immune-mediated, intestinal 
inflammation.15–17 IL-10−/− mice maintained in germ-free 
conditions do not develop intestinal inflammation. However, 
once colonized with conventional or specific pathogen-free 
(SPF) microbiota, IL-10−/− mice develop chronic intestinal 
inflammation.18 The animals were obtained from Jackson 
Laboratory (Bar Harbor, ME, USA), where they were kept 
in SPF conditions and colonized by artificially constructed 
microbiota. Five week-old mice were delivered to the 
Jagiellonian University Medical College animal facility in 
Anima-Lab (Poznań, Poland) transport cages with SPF guar-
anteed conditions. SPF standard was maintained throughout 
the experiments; the animals were kept in MICRO-ISOLA-
TOR IIIH (Anima-Lab) cages fitted with specific air filters 
and fed sterile food and water. According to suggestions 
obtained from the Jackson Laboratories, the experiment was 
initiated when the body temperature of 70% of animals low-
ered from the normal of 37.5°C–38°C to 36.9°C–37.0°C and 
displayed other clinical symptoms, such as lower food intake 
and a visible worsening of physical condition, which suggest 
the beginning of intestinal inflammation. To achieve these 
precise data, body temperature of all animals was measured 
every 8 hours using rectal thermometry. Other parameters 
were noted simultaneously. The study was performed under 
permission 71/2013 of the local Jagiellonian University 
Bioethical Committee for Studies on Animals.
The study was performed on 40 animals, which were 
divided into four experimental groups, with ten mice in each 
group. Group I (control group) mice were not supplemented 
with lactobacilli. Group II (catalase group) mice were supple-
mented with human L. plantarum 30B strain, which showed 
a high catalase enzyme activity. Group III (dismutase group) 
animals were supplemented with human L. acidophilus 900 
strain, which demonstrated high dismutase-like activity, and 
group IV (mix group) animals were supplemented with both 
L. plantarum 30B and L. acidophilus 900.
Preparation of bacterial strains and animal 
supplementation regimens
Bacterial suspensions for animal supplementation were pre-
pared daily during the experiment by suspending a 24-hour 
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culture in 10 mL PBS and adjusting the final concentration 
of bacterial cells to 1 × 108 CFU/mL, as confirmed using a 
McFarland scale and a viable count method.19 During 23 
days of the experiment, the animals were given the bacte-
rial suspensions in autoclaved drinking water which was 
changed for new batch of the bacteria 3× daily, according 
to following schedule. Group II mice were given 100 µL of 
L. plantarum strain 30B suspension containing 1 × 108 CFU/
mL three times a day. Group III mice were given 100 µL of 
L. acidophilus strain 900 suspension containing 1 × 108 CFU/
mL three times a day, whereas group IV mice were given a 
mixture of both Lactobacillus strains in equal proportions 
(50 µL L. acidophilus 900 plus 50 µL L. plantarum 30B). 
Group I mice served as controls and were fed with sterile 
water without bacteria. Supplementation started on the first 
day of the experiment. On day 0 (the day before supplementa-
tion began) and on day 23 (the end of the experiment), fecal 
samples were collected from animals. Body temperature 
was measured on days 0, 5, 10, 15, 20, and 23 using a rectal 
thermometer for rodents VIVARI (Warsaw, Poland). Body 
mass was measured on the same days. On the last day of the 
experiment, the animals were sacrificed by an overdose of 
pentobarbital (Morbital; Biowet, Pulawy, Poland), admin-
istered intraperitoneally at a concentration of 100 mg/kg 
of body mass. At necropsy, intestines were removed for 
microbiological and histopathological studies.
Quantitative examination of feces and intestinal 
tissue for groups of aerobic bacteria and lactobacilli
On days 0 and 23, fecal samples were collected into sterile 
containers. The samples were weighed, placed in 10 mL 
Schaedler’s broth (Difco, Detroit, MI, USA), and homog-
enized. Dilutions were made in Schaedler’s broth and then 
from each dilution, 100 µL samples were transferred onto 
appropriate agar media. Staphylococci were cultured for 
24 hours at 37°C in aerobic conditions on Columbia Agar 
with 5% sheep blood (Difco). Gram-negative bacteria were 
cultured on McConkey’s agar (Biocorp, Warszawa, Poland) 
and enterococci were cultured on Bile EsculinAzide LAB-
agar (Biocorp). Lactobacilli were cultured on MRS Agar 
(Oxoid) and cultivable anaerobic bacteria on Schaedler’s agar 
both in strict anaerobic atmosphere using GENbox anaerobic 
system (bioMerieux, Craponne, France) at 37°C for 48 hours. 
To detect yeast-like fungi, Sabouraud Agar (Difco) was used 
at 37°C for 24 hours in aerobic conditions. Cultured bacteria 
were identified using the following API sets (bioMerieux): 
API 20E (Gram-negative rods), API Staph (staphylococci), 
API Strep (streptococci and enterococci), and API50CHL 
(lactic acid bacteria). Further species identification of 
strains, such as for L. plantarum and L. acidophilus, was 
done by PCR with species-specific primers.20 The primers 
used are listed in Table 2. Isolates identified as L. plantarum 
and L. acidophilus were compared with reference strains 
Table 2 Species-specific primers used to identify Lactobacillus species (from ref 19)
Primer 
pair 
Species Primers Target Sequence (5′–3′) PCR annealing 
temperature 
(°C) 
1 L. acidophilus aci 16si 16s gene agcTgaaccaacagaTTcac 62 
16sii acTaccagggTaTcTaaTcc 
2 L. crispatus cri 16si 16s gene gTaaTgacgTTaggaaagcg 60 
16sii acTaccagggTaTcTaaTcc 
3 L. gasseri gasi 16s-23s spacer gagTgcgagagcacTaaag 55 
gasii cTaTTTcaagTTgagTTTcTcT 
4 L. johnsonii Joh 16si 16s gene gagcTTgccTagaTgaTTTTa 57 
16sii acTaccagggTaTcTaaTcc 
5 L. plantarum lfpr 16s-23s spacer gccgccTaaggTgggacagaT 55 
Planii TTaccTaacggTaaaTgcga 
6 L. casei Pri 16s-23s spacer cagacTgaaagTcTgacgg 55 
casii gcgaTgcgaaTTTcTTTTTc 
7 L. zeae Zeai 16s-23s spacer TgTTTagTTTTgaggggacg 58 
Zeaii aTgcgaTgcgaaTTTcTaaaTT 
8 L. rhamnosus Pri 16s-23s spacer cagacTgaaagTcTgacgg 58 
rhaii gcgaTgcgaaTTTcTaTTaTT 
9 L. reuteri lfpr 16s-23s spacer gccgccTaaggTgggacagaT 55 
reu aacacTcaaggaTTgTcTga 
10 L. fermentum lfpr 16s-23s spacer gccgccTaaggTgggacagaT 55 
Fermii cTgaTcgTagaTcagTcaag 
11 L. sharpeae shai 16s-23s spacer gaTaaTcaTgTaagaaaccgc 58 
shaii aTaTTgTTggTcgcgaTTcg 
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L. plantarum 30B and L. acidophilus 900 based on specific 
drug sensitivity patterns and growth inhibition zone diam-
eters for the following antimicrobials (Oxoid): vancomycin 
(L. plantarum 30B strain was resistant to vancomycin; L. 
acidophilus 900 was sensitive, 21–22 mm diameter), cip-
rofloxacin (both L. plantarum 30B and L. acidophilus 900 
strains were resistant), and trimethoprim-sulfamethoxazole 
(L. plantarum 30B was sensitive, 25–26 mm diameter; 
L. acidophilus 900 was resistant).
Samples from intestines were taken as follows. At 
necropsy, the GI tract from stomach cardia to anus was 
collected from each animal. The organ was transferred to 
a sterile Petri dish and then sectioned to obtain samples for 
microbiological, fluorescent in situ hybridization (FISH), 
and histopathological studies. The colon contents were 
removed from the lumen and transferred to a sterile test tube, 
weighed, placed in 10 mL Schaedler’s broth, and plated on 
solid media as described earlier. The 1 cm-long colon tissue 
samples were collected from the distal part of the large intes-
tine, 3 cm from the anus. The samples were dissected using a 
sterile scalpel, washed thoroughly in 10 mL PBS (to remove 
remaining planktonic microbes), transferred to a test tube, 
weighed, and carefully fragmented in 1 mL Schaedler’s 
broth using a glass mortar. Dilutions of the homogenized 
samples were made in Schaedler’s broth, and then 100 µL 
samples were plated on solid media and cultured as described 
earlier. Colony identification was performed using API 
tests (bioMerieux).
histopathological examination of intestinal tissue
Histopathological examination was performed on the tissue 
fragments collected from the distal part of the large intes-
tine that had been fixed in 10% formalin and embedded in 
paraffin. The tissues were sectioned to a thickness of 5 µm 
using a cryostat and stained with hematoxylin (Merck) and 
eosin (Merck). Changes in the intensity of inflammation 
in the tissue were evaluated using a semiquantitative scale 
based on Asseman et al with the following modification.21 
For the three parameters, granulocytic submucosal infiltrate, 
granulocytic transmural infiltrate, and intracryptic abscesses, 
appropriate point values from 0 to 2 were adjusted. A higher 
final result (the sum of values for all parameters between 
0 and 6 points) indicates a worse clinical state.
Fluorescent in situ hybridization
A sample of the mouse colon was placed in 100 µL ster-
ile, distilled water and fragmented using a mortar. Then a 
10 µL volume from the mixture was placed on microscopic 
slide (Super Frost R Plus; Menzel Glaser, Braunschweig, 
Germany) for FISH. The procedure and the probes used (EUB 
for all bacterial species; Lab158 for lactobacilli/enterococci; 
Enc for Enterococcus; and EC for Enterobacteriaceae) were 
in accordance with previously published methods.22–24
statistical analysis
Statistical analysis was performed using SAS software 
for analysis of variance (ANOVA) and Tukey’s test. The 
results are presented as averages ± standard error (SE). Sta-
tistical significance was considered as follows: *P,0.05; 
**P,0.01.
Results
antioxidative activity of Lactobacillus 
strains
All collected strains showed extracellular H
2
O
2
 produc-
tion at the time relevant to superoxide anion dismutation, 
although it was more commonly seen in L. acidophilus and 
L. delbrueckii strains than in L. plantarum strains. Strains 
L. acidophilus 900 and L. delbrueckii 713 displayed the high-
est superoxide anion radical dismutation activity in 2 hours. 
The L. plantarum strains, on the other hand, showed increased 
ability to degrade chemically pure H
2
O
2
 in comparison to 
the tested strains of other species. In 24 hours L. plantarum 
718, L. plantarum 753, L. plantarum 771, L. plantarum 807, 
and L. plantarum 30B demonstrated the highest catalase 
activity. Detailed results of the performed tests are shown 
in Table 1. Based on them, strains L. acidophilus 900 and 
L. plantarum 30B were chosen for oral supplementation of 
the experimental animals.
Observation of clinical parameters 
in animals
Of the 40 experimental mice, 29 survived until the end of 
the experiment. Of the 11 animals that died, two belonged 
to group I, two were from group II, one was from group III, 
and six were from group IV. Except for one mouse from 
group IV which died on fifth day and one animal from 
group II which died on the 13th day, all other mice died at 
the end of the experiments, between days 21 and 23, which 
was related to progress in gut inflammation typical for this 
IBD animal model. Over the course of the experiment, body 
temperature dropped variously in the respective groups; for 
example, the drop in the body temperature of group I mice 
was visible until day 15, at which point the temperature 
slowly rose (Figure 1). On day 23, the body temperature of 
group IV mice (P,0.05) and group II (0.01,P,0.05) was 
significantly lower than that of group I mice. Reduction in 
body temperature of group III mice occurred slowly and was 
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not significantly different from that of group I (Figure 1). 
Over time, all groups experienced a gradual decrease in 
body mass. As with body temperature, group I displayed 
a decrease in body mass until day 15, and then their body 
mass returned to the original value. The largest drop in 
body mass compared to group I was observed in group II 
(0.01,P,0.05) and group IV (0.01,P,0.05) on day 23 
(Figure 2). Furthermore, the mortality rate in group IV was 
the highest (60% died), which was observed after 21 days 
of the experiment and 63 supplementation doses of the 
L. plantarum 30B and L. acidophilus 900 mixture.
Quantitative microbiological analyses of 
feces and intestinal tissues
We compared the cultivable intestinal bacteria population 
related to inflammatory changes in experimental mice models 
of IBD. We found that the fecal samples collected from 
all groups on days 0 and 23 showed a significant increase 
in the numbers of Enterococcus spp., Enterobacteriaceae 
rods, and yeast-like fungi (Table 3). In addition, group II 
and group IV mice experienced a significant (P,0.05) 
decrease in the numbers of staphylococci as compared to 
Figure 1 changes in the animals’ body temperature on selected study days.
Notes: Statistical significance was verified against group I (control) and considered as follows: *P,0.05; **P,0.01.
°
Figure 2 changes in the animals’ body mass on selected study days.
Notes: Statistical significance was verified against group I (control) and considered as follows: *P,0.05; **P,0.01.
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the control. The homogenized colon samples collected on 
day 23 of the experiment represented the mucosal adherent 
bacteria. In these samples, we observed that the populations 
of these major groups were comparable among experimental 
groups of mice, except for the mixed (IV) group. Colonic 
tissues taken from the mixed group contained significantly 
higher populations of bacteria from the Enterobacteriaceae 
family in comparison to that taken from other animal groups 
(Table 4). Group I animals showed a slight decrease in the 
total numbers of bacteria since they were not supplemented 
with lactobacilli. Cultivable anaerobic bacteria were found 
only in the feces of group IV animals by the end of the 
experiment.
histopathological examination of tissues 
and Fish
Histopathological evaluation revealed that the most pro-
nounced changes in granulocytic submucosal infiltration, 
transmural infiltration, and the presence of intracryptic 
abscesses were observed in groups II and IV, the histopatho-
logical scores of which were 4.75 and 4.8, respectively. 
(Table 5) Group III achieved only a value of 2.75, which 
indicates a less severe inflammatory response in these mice. 
The control group showed only mild inflammation scores. 
The colon tissues from group IV mice were the most severely 
affected. The histopathological examination of all the sam-
ples obtained from group IV showed intracryptic abscesses, 
which indicates an ongoing acute inflammatory process in the 
intestinal wall (Figure 3). Using FISH methods with specific 
probes, we demonstrated that Enterococcus populations in 
homogenized intestinal samples taken from group IV mice 
exceeded 1.0 × 104 CFU/mL. This corresponded to the pres-
ence of intracryptic abscesses as observed in histopathologi-
cal sections (Figure 4).
Discussion
In vitro studies on the antioxidative properties of lactobacilli 
were performed using strains originating from human or 
mouse GI tracts. Independent of their origin, L. plantarum 
strains demonstrated an ability to break down H
2
O
2
, which 
requires catalase enzyme activity. In fact, the mechanisms 
and uses of the antioxidative properties of this species have 
been studied frequently.25–27 On the other hand, we found 
that L. acidophilus and L. delbrueckii strains had the highest 
activity for liberation of extracellular H
2
O
2
, which requires 
superoxide anion dismutation. Thus, in mixed populations, 
for example in gut microbiota, some Lactobacillus strains 
carry out the superoxide anion radical dismutation to H
2
O
2
, 
while other lactobacilli have catalase and can degrade H
2
O
2
 to 
oxygen and water. From the 25 lactobacilli evaluated in this 
study, the highest catalase activity was observed in the human 
L. plantarum 30B strain, and the strongest superoxide anion 
dismutation was observed in the human strain L. acidophilus 
900. We chose these two strains of human origin for in vivo 
experiments because of their expected future application. 
As far as we know, all published studies on the influence of 
lactobacilli on experimental chronic colitis in mice models 
were performed using human strains.
In the animal model of IBD, we observed that the 
strain L. acidophilus 900 with dismutase-like activity is 
more effective in suppressing the inflammatory process 
than the L. plantarum 30B, which produces catalase. 
Table 4 Quantitative differences among populations of selected microbial groups and taxa (cFU/g) isolated from colon tissue on the 
23rd day of the experiment
Selected microbial 
groups
Number of bacteria (CFU/g tissue) Statistical significance
Group I
(control)
(n=8)
Group II
(catalase)
(n=8)
Group III
(dismutation)
(n=9)
Group IV
(mix)
(n=4)
Total bacterial population 6.1 × 106 4.6 × 106 5.5 × 106 3.3 × 106
Lactobacillus spp. 5.9 × 106 3.7 × 106 1.6 × 106 4.1 × 105
L. plantarum 1.5 × 106 6.0 × 104 1.4 × 106 3.7 × 105
L. acidophilus 4.4 × 106 3.6 × 106 2.2 × 105 4.7 × 104
Enterococcus spp. 1.5 × 105 6.8 × 105 1.2 × 106 2.6 × 106
Enterobacteriaceae 9.9 × 104 2.0 × 105 2.6 × 106 2.3 × 107 *(between groups II and IV)
**(between groups I and IV)
Staphylococcus spp. 3.0 × 102 0 6.6 × 102 0
Yeasts 1.1 × 104 1.2 × 103 3.9 × 104 1.4 × 103
anaerobes 0 0 0 0
Notes: Statistical significance: *P,0.05; **P,0.01. a value of 0 indicates populations below 1 × 102 cFU (due to the limit of the viable count method).
Abbreviation: cFU, colony-forming unit.
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Table 5 Histopathological examination of inflammatory changes in the intestinal tissues of the tested mice
Group/number 
of mice in the 
group
Granulocytic 
infiltration in the 
intestinal wall
Granulocytic 
exudation in 
the lumen
Presence 
of crypt 
abscesses
The total 
number 
of points
Average 
number 
of points
SD Comments
i/1 0 0 0 0 0.1 0.353 –
i/2 0 0 0 0 –
i/3 0 0 0 0 –
i/4 0 0 0 0 –
i/5 0 0 0 0 –
i/6 1 0 0 1 –
i/7 0 0 0 0 –
i/8 0 0 0 0 –
i/9 Death Death Death Death Death on day 18
i/10 Death Death Death Death Death on day 17
ii/1 2 2 2 6 4.75 1.112 –
ii/2 – – – – not done
ii/3 2 2 1 5 –
ii/4 2 2 1 5 –
ii/5 2 2 2 6 –
ii/6 1 1 1 3 –
ii/7 2 1 1 4 –
ii/8 2 1 1 4 –
ii/9 Death Death Death Death Death on day 13
ii/10 Death Death Death Death Death on day 20
iii/1 2 2 0 4 2.75 1.164 –
iii/2 1 1 0 2 –
iii/3 1 0 0 1 –
iii/4 1 1 0 2 –
iii/5 1 0 1 2 –
iii/6 – – – – not done
iii/7 2 1 1 4 –
iii/8 2 1 1 4 –
iii/9 1 1 1 3 –
iii/10 Death Death Death Death Death on day 22
iV/1 2 2 2 6 4.8 1.5 –
iV/2 1 2 1 4 –
iV/3 1 1 1 3 –
iV/4 2 2 2 6 –
iV/5 Death Death Death Death Death on day 5
iV/6 Death Death Death Death Death on day 21
iV/7 Death Death Death Death Death on day 22
iV/8 Death Death Death Death Death on day 22
iV/9 Death Death Death Death Death on day 22
iV/10 Death Death Death Death Death on day 22
Notes: Samples for histological evaluation were obtained at necropsy performed on day 23. Histological evaluation is reported in a 0–6 graded scale. Granulocytic infiltration 
in the intestinal wall: 0 – none, 1 – scanty, 2 – abundant. granulocytic exudation in the lumen: 0 – none, 1 – sparse, 2 – profuse. intracryptic abscesses: 0 – none, 1 – single, 
2 – numerous.
This anti-inflammatory effect was principally observed 
during the initial phase of the study when both mouse body 
temperature and mass were measured. The drop in these 
parameters was much slower in mice supplemented with 
L. acidophilus 900 than in mice fed with catalase-producing 
lactobacilli or a mixed population of lactobacilli.
Oxidative stress in mucosa inflammation is an outcome 
of antioxidant depletion and oxidant/antioxidant imbalance. 
Under such conditions, an antioxidant system will not provide 
protection from the ROS-induced oxidative modification 
of lipids and proteins. In such situation, bacteria producing 
antioxidant enzymes attached to mucosa may interfere with 
this imbalance providing exogenous antioxidant enzymes to 
the underlying inflamed tissue. It is likely that the process of 
inactivating ROS by transforming superoxide anion radical 
to a less toxic H
2
O
2
 plays a more important role in reduc-
ing inflammation than the process of converting H
2
O
2
 to 
oxygen and water. This may be explained by data showing 
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Figure 3 histopathological section of intestinal walls.
Notes: (A) normal structure of intestines in control group. h&e, 200×. (B) Significantly inflamed intestine in group II; with mixed-cellular infiltrate in the mucosa, some 
crypts contain micro abscesses (*). H&E, 200×. (C) Significant interstitial inflammation and micro abscesses (*) were observed in group III. H&E, 200×. (D) group iV mice 
showed mild infiltrate in the lamina propria, composed chiefly of mononuclear cells. H&E, 200×.
that the activity of catalase but not SOD can be drastically 
reduced in the presence of superoxide radicals, the genera-
tion of which can reach up to 3 nmol/min under pathological 
conditions.28
These observations are in accordance with those reported 
by LeBlanc et al, who showed that animals supplemented 
with lactobacilli with SOD activity were less prone to losing 
weight after 5–7 days of trinitrobenzenesulfonic acid (TNBS) 
administration.29 More importantly, 10 days after TNBS 
treatment, there were no differences in body mass between 
the experimental and control groups. Our study occurred over 
the same time period, 5–10 days, and we obtained similar 
results; the animals receiving both studied strains also showed 
a slight body mass increase after 10 days.
Mice in group I developed transient intestinal inflam-
mation when they were about 8 weeks old, and it lasted for 
approximately two more weeks. Over the following experi-
mental days, we observed a gradual recovery to the initial 
state and did not observe any clinical or histopathological 
signs of IBD. This course of intestinal inflammation has been 
previously described in the C57Bl/6J mouse IL-10−/− line.10 
To produce an aggressive form of IBD, these mice need to 
be infected by pathogens such as Helicobacter hepaticus 
or Enterococcus faecalis; however, the less severe form 
of inflammation more closely resembles human ulcerative 
colitis.30 Oral administration of L. plantarum 30B strains or 
a mixture of both lactobacilli strains (L. plantarum 30B and 
L. acidophilus 900) worsened the health of the mice in the 
later phase of the experiment. The mice displayed a decrease 
in body mass and temperature and aggravated histopathologi-
cal intestinal inflammation was noted. These effects were 
unexpected, but it may be explained by too high dosage of the 
Figure 4 Enterococcus bacteria present in intracryptic abscess in intestines of 
group iV mice.
Notes: Nuclei of the intestinal epithelial cells stained with the fluorescent stain 
DaPi, and bacteria of the Enterococcus genus visualized using the ent probe, labeled 
with CY3. Magnification 1,000×.
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Lactobacillus bacteria which antigens like as peptidoglycan 
and exopolysaccharides might stimulate the mucosal immune 
system and trigger the inflammation. Other authors who used 
similar mouse model also observed that the conditions of 
their mice worsened, but did not improve, in the later stages 
of the experiment (over 5 weeks). Administration of the 
complex mixture of probiotic preparation VSL #3 also did 
not reduce the inflammatory reaction.31 Carroll et al observed 
that administration of high doses of L. gasseri triggered the 
progression of the inflammatory state, which they described 
as the development of an aggressive form of intestinal inflam-
mation after introduction of a significant antigenic stimulus.10 
It should be mentioned that the clinical status worsened and 
mortality rate increased as inflammation progressed in this 
mice model. This explains why the progress involved also 
control animals.
In mice supplemented with both strains of lactobacilli, 
we observed quantitative changes in the numbers of these 
bacterial groups, the overgrowth of which is related to the 
worsening of the intestinal inflammation. Thus, there was a 
significant increase in the populations of Enterobacteriaceae 
and Enterococcus. According to the literature, an increase in 
the number of Gram-negative bacteria located in the intestinal 
lumen, especially E. coli, is a biological marker of inflam-
mation, which causes fecal occult blood.14
Group IV mice were in the worst condition, which was 
indicated by their high mortality rate (60%). In all mice of this 
group, we observed intracryptic abscesses containing entero-
cocci, which indicates acute inflammation in the intestinal wall. 
Bacteria from the Enterococcus genus are known to induce 
intestinal inflammation in this mouse model.32 Huycke et al 
have demonstrated that E. faecalis produces large quantities 
of superoxide anion radical in the intestines, which damages 
the intestinal epithelium.33 This observation may explain the 
formation of intracryptic abscesses in the intestinal wall of 
IL-10−/− mice. It is known that the formation of abscesses is 
characteristic of infections caused by Gram-positive cocci, such 
as Staphylococcus spp. and Enterococcus spp., and their tox-
ins.34 Indeed, using FISH, we demonstrated that the intracryptic 
abscesses in mice showed high numbers of enterococci.
In spite of the adverse effect of the mixed Lactobacillus 
strains used by us in this study, we believe that our approach 
was rational. Moreover, the conclusions of very recent studies 
of LeBlanc group, although based on genetically modified 
lactobacilli, show the importance of using mix microorgan-
isms with different single properties to increase the individual 
effects and to include more than one mechanism of action 
to ameliorate mucosal inflammation.35 Future studies will 
be needed to estimate optimal dosage of the Lactobacillus 
strains, both given alone or in a mixture, since all groups 
supplemented with lactobacilli developed more severe 
inflammation as observed by histopathological examination 
than those getting no bacteria. This may indicate that the 
bacterial load was too high and caused untowarded inflam-
matory reaction. It is also possible that increased inflamma-
tory response to bacterial load in experimental groups of 
the animals and also in controls could be a specificity of the 
selected animal model since most of aggravated reactions and 
deaths occurred in last days of the observation, ie, in day 18th 
and later. Therefore, future studies should clarify the optimal 
time of observations for IL-10−/− line in C57Bl/6J mouse and/
or should be performed on another animal model.
Conclusion
Our study results demonstrate that it is possible to use selected 
lactobacilli with antioxidative properties related to dismutase 
activity to alleviate at least some symptoms associated 
with IBD. Moreover, our results specifically identified the 
L. acidophilus 900 strain with high dismutase-like activity as 
a promising strain, which can be further tested. In summary, 
Lactobacillus strains that transform superoxide anion radical are 
more effective in alleviating intestinal inflammation in an IBD 
mouse model than the strains producing catalase, suggesting 
that superoxide anion radical is a more toxic ROS than H
2
O
2
.
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